# Enterprise Readiness Package — Clinical Workspace 2.0 / Intelligent Clinical Journey

**Version:** 1.0  
**Date:** 2026-06-26  
**Prototype path:** `/prototype/clinical-workspace-2`  
**Scope:** Informed consent workflow for physicians and patients, including decision support, bilingual education, guardian/interpreter/witness flows, refusal handling, accessibility controls, and auditable evidence.

---

## Package Index

| # | Document | Purpose | Audience |
|---|----------|---------|----------|
| 1 | [UAT Plan](./01-uat-plan.md) | Scope, roles, entry/exit criteria, defect severity, approval gates | UAT lead, clinical operations, QA |
| 2 | [Test Scripts](./02-test-scripts.md) | Step-by-step executable scripts with expected results and evidence | Testers, QA, physicians, nurses |
| 3 | [Clinical Scenarios](./03-clinical-scenarios.md) | Realistic patient cases for IMC-style validation | Clinical leadership, physicians, legal |
| 4 | [Acceptance Criteria](./04-acceptance-criteria.md) | Measurable criteria by capability area | Product, QA, compliance, legal |
| 5 | [Training Materials](./training/) | Practical guides for physicians, nurses, legal reviewers, patients, admins | End users, trainers, support |
| 6 | [Deployment Checklist](./06-deployment-checklist.md) | Controlled rollout tasks and verification points | DevOps, release manager, IT |
| 7 | [Rollback Checklist](./07-rollback-checklist.md) | Safe rollback decision tree and actions | Incident commander, release manager |
| 8 | [Production Readiness Report](./08-production-readiness-report.md) | Final GO / GO WITH OBSERVATIONS / NO GO template | Executive sponsor, clinical leadership |
| 9 | [Executive Readiness Summary](./09-executive-readiness-summary.md) | One-page executive brief on readiness and blockers | CEO, CIO, Medical Director, board |
| 10 | [Risk Register](./10-risk-register.md) | Full project risk register with scoring and mitigation | Enterprise readiness, risk, compliance |
| 11 | [Go-Live Checklist](./11-go-live-checklist.md) | Pre-go-live, day-of, and post-go-live tasks | Release manager, operations, DevOps |
| 12 | [Production Validation Matrix](./12-production-validation-matrix.md) | Capability-to-environment validation mapping | QA, compliance, engineering |
| 13 | [Stakeholder Sign-Off Templates](./13-stakeholder-signoff-templates.md) | Phase-gate sign-off for all stakeholders | Executive sponsor, release manager |
| 14 | [Operational Runbook](./14-operational-runbook.md) | Day-to-day operational procedures and incident response | Operations, DevOps, SRE |
| 15 | [Support Handover Guide](./15-support-handover-guide.md) | Tier 1/2/3 support model, FAQs, and escalation | Support lead, help desk |
| 16 | [Hypercare Plan](./16-hypercare-plan.md) | First-30-days intensive support and exit criteria | Operations, support, clinical SME |
| 17 | [Known Issues Register](./17-known-issues-register.md) | Documented limitations, workarounds, and closure plans | Product, engineering, QA |
| 18 | [Open Risks Register](./18-open-risks-register.md) | Live residual risks accepted at go-live or pilot | Risk owners, executive sponsor |
| 19 | [Final Enterprise Readiness Index](./19-final-enterprise-readiness-index.md) | Master index, directory tree, readiness score, recommendation | All stakeholders, external auditor |
| A1 | [Mock Evidence Package](./evidence/mock-evidence-package.md) | Example exported evidence and audit artifacts | Compliance, legal, QA |

---

## Key Decisions Made

1. **Prototype-only validation scope.** All validation artifacts reference `/prototype/clinical-workspace-2`. No production routes, signing workflows, OTP/SMS, PDF, or WathiqNote flows are modified.
2. **Deterministic mock data.** UAT scripts use the fixed mock patients, encounters, and procedures in the prototype so tests are reproducible without real PHI.
3. **Evidence-first design.** Every critical step (patient decision, signature, alert acknowledgment, refusal) generates an auditable timeline event and an evidence hash.
4. **Bilingual by default.** Acceptance criteria require full Arabic and English support, with right-to-left layout validated for Arabic screens.
5. **Guardian/interpreter/witness as required participants.** The Clinical Knowledge Package resolves required participants based on capacity, language, and risk level; UAT verifies each combination.
6. **Refusal is a first-class outcome.** Refusal is captured with its own acknowledgment, signature, confirmation, and audit events.
7. **Accessibility is a release gate.** Text size, high contrast, and language controls must be verified before GO.
8. **Rollback does not delete data.** Active sessions are preserved; the feature is disabled via feature flags and route alias changes.

---

## Remaining Risks

The detailed risk register, known issues, and open risks are maintained in the following documents:

- [10-risk-register.md](./10-risk-register.md)
- [17-known-issues-register.md](./17-known-issues-register.md)
- [18-open-risks-register.md](./18-open-risks-register.md)

The highest residual risks at this date are:

| Risk | Impact | Mitigation | Owner |
|------|--------|------------|-------|
| Patient-facing production route `/sign/[token]/workflow` does not exist in this branch. | High — blocks real patient remote signing. | Keep remote signing in prototype preview mode; plan separate build ticket before production. | Product / Engineering |
| Mock Clinical Knowledge Engine does not integrate with live CKE/IMC services. | Medium — package resolution logic may differ. | Validate against CKE API contract in next sprint; acceptance criteria require mapping review. | Clinical Knowledge team |
| No load/performance testing on signing concurrency. | Medium — unknown behavior under peak load. | Add performance criteria and run load tests in staging before GO. | QA / DevOps |
| Legal review of refusal language and patient copy disclaimers pending. | High — could affect defensibility. | Route final copy through legal affairs before production release. | Legal Affairs |
| Accessibility audit by a third party not yet performed. | Medium — WCAG conformance unverified. | Run automated a11y scans in UAT; schedule third-party audit before full rollout. | Compliance |

---

## Recommended Next Action

1. **Schedule UAT execution** using the [UAT Plan](./01-uat-plan.md) and [Test Scripts](./02-test-scripts.md) with at least two physicians, one nurse, one legal reviewer, and one patient representative.
2. **Resolve the patient-facing remote signing route gap** by creating a separate engineering ticket to build `/sign/[token]/workflow` behind a feature flag.
3. **Run the standalone smoke script** (`node qa-screenshots/capture-workspace-2-flow.mjs`) and attach screenshots to the readiness report.
4. **Obtain sign-off** from clinical leadership, legal affairs, compliance, IT, and information security before changing the readiness report status from **NO GO** to **GO WITH OBSERVATIONS**.

---

## Change Log

| Version | Date | Author | Change |
|---------|------|--------|--------|
| 1.0 | 2026-06-26 | Enterprise Readiness Lead | Initial package created. |
